Behavioral defects induced by chronic social defeat stress are protected by Momordica charantia polysaccharides via attenuation of JNK3/PI3K/AKT neuroinflammatory pathway

被引:38
作者
Deng, Zhifang [1 ,2 ]
Yuan, Cheng [3 ]
Yang, Jian [2 ,4 ]
Peng, Yan [1 ,2 ]
Wang, Wei [2 ,4 ]
Wang, Yan [1 ,2 ]
Gao, Wenqi [2 ,4 ]
机构
[1] China Three Gorges Univ, Dept Pharm, Coll Clin Med Sci 1, Yichang 443000, Peoples R China
[2] Yichang Cent Peoples Hosp, Yichang 443000, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Hubei, Peoples R China
[4] China Three Gorges Univ, Dept Cent Expt Lab, Coll Clin Med Sci 1, Yichang 443000, Peoples R China
基金
中国国家自然科学基金;
关键词
Momordica charantia polysaccharides (MCP); depressive behaviors; neuroinflammation; c-Jun N-terminal protein kinase (JNK3); SIGNALING PATHWAY; OXIDATIVE STRESS; DEPRESSIVE SYMPTOMS; NEUROTROPHIC FACTOR; ANTIDEPRESSANT; ACTIVATION; ISOFORMS; NEUROPROTECTION; NEUROGENESIS; ANTIOXIDANT;
D O I
10.21037/atm.2018.12.08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this study was to evaluate the protective effects of Mornordica charantia polysaccharides (MCP) on depressive-like behaviors. Methods: The chronic social defeat stress (CSDS) mice model was used to evaluate the effects of MCP and their underlying mechanisms. Social interaction test (SIT), sucrose preference test (SPT), and tail suspension test (TST) were performed for behavioral assessments. Expression levels of inflammation mediators and phosphatidylinositol 3-kinase (PI3K) activity were determined using commercial ELISA kits. The expression of key proteins in the c-Jun N-terminal protein kinase (JNK3)/PI3K/protein kinase B (AKT) pathway were measured using western blot and RT-PCR. Results: The results showed that chronic administration of MCP (100, 200, 400 mg/kg/day) significantly prevented depressive-like behaviors in CSDS mice as assessed by SIT, TST and SPT. Elevated levels of proinflammatory cytokines [tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta)], and expression of JNK3, c-Jun, P-110 beta proteins were observed in the hippocampus of CSDS mice. Moreover, the activity of PI3K and phosphorylation level of AKT were reduced in the hippocampus of CSDS mice. Interestingly, the administration of MCP reversed these changes. Furthermore, the protective effects of MCP on CSDS mice were partly inhibited by the PI3K inhibitor, LY294002. Conclusions: In conclusion, the protective effects of MCP against depressive-like behaviors in CSDS mice might be due to a reduction in neuroinflammation and the down-regulation of the JNK3/PI3K/AKT pathway in the hippocampus.
引用
收藏
页数:10
相关论文
共 41 条
  • [1] [Anonymous], 2017, J PSYCHOPHARMACOL, DOI DOI 10.1177/0269881117711708
  • [2] SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
    Bennett, BL
    Sasaki, DT
    Murray, BW
    O'Leary, EC
    Sakata, ST
    Xu, WM
    Leisten, JC
    Motiwala, A
    Pierce, S
    Satoh, Y
    Bhagwat, SS
    Manning, AM
    Anderson, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13681 - 13686
  • [3] Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study
    Black, C. N.
    Penninx, B. W. J. H.
    Bot, M.
    Odegaard, A. O.
    Gross, M. D.
    Matthews, K. A.
    Jacobs, D. R., Jr.
    [J]. TRANSLATIONAL PSYCHIATRY, 2016, 6 : e743 - e743
  • [4] The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting
    Bogoyevitch, Marie A.
    [J]. BIOESSAYS, 2006, 28 (09) : 923 - 934
  • [5] A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
    Borsello, T
    Clarke, PGH
    Hirt, L
    Vercelli, A
    Repici, M
    Schorderet, DF
    Bogousslavsky, J
    Bonny, C
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1180 - 1186
  • [6] Specific pathophysiological functions of JNK isoforms in the brain
    Brecht, S
    Kirchhof, R
    Chromik, A
    Willesen, M
    Nicolaus, T
    Raivich, G
    Wessig, J
    Waetzig, V
    Goetz, M
    Claussen, M
    Pearse, D
    Kuan, CY
    Vaudano, E
    Behrens, A
    Wagner, E
    Flavell, RA
    Davis, RJ
    Herdegen, T
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (02) : 363 - 377
  • [7] Involvement of PI3K, GSK-3β and PPARγ in the antidepressant-like effect of folic acid in the forced swimming test in mice
    Budni, Josiane
    Lobato, Kelly R.
    Binfare, Ricardo W.
    Freitas, Andiara E.
    Costa, Ana Paula
    Martin-de-Saavedra, Maria Dolores
    Leal, Rodrigo B.
    Lopez, Manuela G.
    Rodrigues, Ana Lucia S.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (05) : 714 - 723
  • [8] Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database
    Coupland, Carol
    Hill, Trevor
    Morriss, Richard
    Moore, Michael
    Arthur, Antony
    Hippisley-Cox, Julia
    [J]. BMC MEDICINE, 2018, 16
  • [9] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [10] Effects of Striatal ΔFosB Overexpression and Ketamine on Social Defeat Stress-Induced Anhedonia in Mice
    Donahue, Rachel J.
    Muschamp, John W.
    Russo, Scott J.
    Nestler, Eric J.
    Carlezon, William A., Jr.
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 76 (07) : 550 - 558